Trump’s bully boy tactics bringing Big Pharma to heel
Determination to cut prices for medicines in US may yet pile pressure on creaking European health budgets
Determination to cut prices for medicines in US may yet pile pressure on creaking European health budgets
When blockbuster drugs lose intellectual property protections it can wipe out billions of dollars in revenue for companies
Move is latest investment by big drugmaker in US
Deal will accelerate winding down of Malin, which has returned hundreds of millions of euro to investors in recent years
Roche descendant André Hoffmann talks pharma, feuds and ESG as he takes a stand against ‘arrogance’ of Trump and Musk
It would bring an end to the rollercoaster ride investors have endured since it floated nine years ago
Continent’s top firms drove most of European equity gains last year
Swiss pharma group says Ireland among slowest countries in Europe to pay for new medicines as it reports €116m profit
Pharmaceutical-related products accounted for almost two-thirds of Irish goods exports last year
WRC adjudicator says case ‘concerning’ as ‘there are few private sector organisations which can have a greater impact on public safety and welfare than a pharmaceutical company’
Sportswear companies among fallers after downbeat profit forecast from US retailer Foot Locker
Shares in Swiss pharma group rally after analyst discovers data on immunotherapy medicine on website
Company expects work to decommission Swiss group’s only manufacturing site in Ireland will continue until 2026
Drugmaker’s Xevudy fails to tackle most prevalent variants of coronavirus, say US regulators
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices